FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2785079080> ?p ?o ?g. }

• W2785079080 endingPage "1390" @default.
• W2785079080 startingPage "1387" @default.
• W2785079080 abstract "Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterised by long bones and various other organs’ involvements.1 Tissues are infiltrated by CD68+ CD1a− foamy histiocytes.2 Therapeutic options are pegylated interferon-α,3 cladribine,4 mTOR inhibitors5 and anakinra in mild forms of ECD.6 7 Conversely, targeted BRAF or MEK inhibitor therapies are used for refractory or life-threatening ECD manifestations.8 9 All these therapies have frequent side effects. Interferon-α leads to fatigue, cytopenias and autoimmune diseases. Anakinra needs subcutaneous daily injections, with frequent local intolerance. Targeted therapies cause skin cancers, QT allongement, rhabdomyolysis and haemorrhage,10 and we lack long-term safety data with these drugs. Moreover, targeted therapies are not available in all countries. Thus, there is an unmet need for improving treatments in many patients with ECD, particularly in countries where access to targeted therapies is complicated or impossible.Although our comprehension of this disease has recently moved from inflammatory to clonal myeloproliferative disease,11 the accumulation of pathological histiocytes leads to an increase of several cytokines in blood and affected tissues. Cytokine/chemokine network has been described in ECD lesions, and most of these factors are regulated by tumour necrosis factor alpha (TNF-α), which is also expressed in ECD lesions and serous fluids like pericardial effusion12–14 and has been implicated in ECD pathogenesis in in vitro models.15 Two ECD patients with cardiovascular involvement were successfully treated with infliximab, a TNF-α monoclonal chimeric antibody, achieving an improvement of symptoms, cardiac involvement and function.14 We aim to determine the efficacy of infliximab in a larger series of patients with ECD.We retrospectively reviewed …" @default.
• W2785079080 created "2018-02-02" @default.
• W2785079080 creator A5003392643 @default.
• W2785079080 creator A5006797325 @default.
• W2785079080 creator A5025440991 @default.
• W2785079080 creator A5034623450 @default.
• W2785079080 creator A5037151870 @default.
• W2785079080 creator A5040294256 @default.
• W2785079080 creator A5041168553 @default.
• W2785079080 creator A5070179654 @default.
• W2785079080 date "2018-01-23" @default.
• W2785079080 modified "2023-10-18" @default.
• W2785079080 title "Efficacy of infliximab in the treatment of Erdheim-Chester disease" @default.
• W2785079080 cites W1744607539 @default.
• W2785079080 cites W1987596886 @default.
• W2785079080 cites W2014207964 @default.
• W2785079080 cites W2027620575 @default.
• W2785079080 cites W2077495741 @default.
• W2785079080 cites W2093904252 @default.
• W2785079080 cites W2095514651 @default.
• W2785079080 cites W2106451155 @default.
• W2785079080 cites W2126417952 @default.
• W2785079080 cites W2133007031 @default.
• W2785079080 cites W2134320323 @default.
• W2785079080 cites W2295097092 @default.
• W2785079080 cites W2328942332 @default.
• W2785079080 cites W2529470637 @default.
• W2785079080 cites W2583492888 @default.
• W2785079080 cites W2593045216 @default.
• W2785079080 cites W2724414938 @default.
• W2785079080 doi "https://doi.org/10.1136/annrheumdis-2017-212678" @default.
• W2785079080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29363511" @default.
• W2785079080 hasPublicationYear "2018" @default.
• W2785079080 type Work @default.
• W2785079080 sameAs 2785079080 @default.
• W2785079080 citedByCount "22" @default.
• W2785079080 countsByYear W27850790802018 @default.
• W2785079080 countsByYear W27850790802019 @default.
• W2785079080 countsByYear W27850790802020 @default.
• W2785079080 countsByYear W27850790802021 @default.
• W2785079080 countsByYear W27850790802022 @default.
• W2785079080 crossrefType "journal-article" @default.
• W2785079080 hasAuthorship W2785079080A5003392643 @default.
• W2785079080 hasAuthorship W2785079080A5006797325 @default.
• W2785079080 hasAuthorship W2785079080A5025440991 @default.
• W2785079080 hasAuthorship W2785079080A5034623450 @default.
• W2785079080 hasAuthorship W2785079080A5037151870 @default.
• W2785079080 hasAuthorship W2785079080A5040294256 @default.
• W2785079080 hasAuthorship W2785079080A5041168553 @default.
• W2785079080 hasAuthorship W2785079080A5070179654 @default.
• W2785079080 hasConcept C126322002 @default.
• W2785079080 hasConcept C16005928 @default.
• W2785079080 hasConcept C2777138892 @default.
• W2785079080 hasConcept C2779134260 @default.
• W2785079080 hasConcept C2779945361 @default.
• W2785079080 hasConcept C2780174970 @default.
• W2785079080 hasConcept C2781228260 @default.
• W2785079080 hasConcept C71924100 @default.
• W2785079080 hasConceptScore W2785079080C126322002 @default.
• W2785079080 hasConceptScore W2785079080C16005928 @default.
• W2785079080 hasConceptScore W2785079080C2777138892 @default.
• W2785079080 hasConceptScore W2785079080C2779134260 @default.
• W2785079080 hasConceptScore W2785079080C2779945361 @default.
• W2785079080 hasConceptScore W2785079080C2780174970 @default.
• W2785079080 hasConceptScore W2785079080C2781228260 @default.
• W2785079080 hasConceptScore W2785079080C71924100 @default.
• W2785079080 hasIssue "9" @default.
• W2785079080 hasLocation W27850790801 @default.
• W2785079080 hasLocation W27850790802 @default.
• W2785079080 hasOpenAccess W2785079080 @default.
• W2785079080 hasPrimaryLocation W27850790801 @default.
• W2785079080 hasRelatedWork W2009699380 @default.
• W2785079080 hasRelatedWork W2033249972 @default.
• W2785079080 hasRelatedWork W2062206141 @default.
• W2785079080 hasRelatedWork W2096722802 @default.
• W2785079080 hasRelatedWork W2136795229 @default.
• W2785079080 hasRelatedWork W2150415598 @default.
• W2785079080 hasRelatedWork W2273630113 @default.
• W2785079080 hasRelatedWork W2785079080 @default.
• W2785079080 hasRelatedWork W2978650559 @default.
• W2785079080 hasRelatedWork W3217088262 @default.
• W2785079080 hasVolume "77" @default.
• W2785079080 isParatext "false" @default.
• W2785079080 isRetracted "false" @default.
• W2785079080 magId "2785079080" @default.
• W2785079080 workType "article" @default.